Nu Skin Enterprises Stock Filter Stocks by Fundamentals
NUS Stock | USD 12.47 0.28 2.20% |
Nu Skin Enterprises fundamentals help investors to digest information that contributes to Nu Skin's financial success or failures. It also enables traders to predict the movement of NUS Stock. The fundamental analysis module provides a way to measure Nu Skin's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nu Skin stock.
NUS | Shares Owned by Insiders |
Nu Skin Institutional Holders
Institutional Holdings refers to the ownership stake in Nu Skin that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Nu Skin's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Nu Skin's value.Shares | Aristotle Capital Boston, Llc | 2023-12-31 | 799.2 K | Northern Trust Corp | 2023-12-31 | 551.7 K | Goldman Sachs Group Inc | 2023-12-31 | 492.1 K | Norges Bank | 2023-12-31 | 459.8 K | Victory Capital Management Inc. | 2023-12-31 | 458.7 K | Two Sigma Advisers, Llc | 2023-12-31 | 446.9 K | Proshare Advisors Llc | 2023-12-31 | 437.8 K | Voloridge Investment Management, Llc | 2023-09-30 | 427.9 K | American Century Companies Inc | 2023-12-31 | 361.8 K | Blackrock Inc | 2023-12-31 | 8.5 M | Vanguard Group Inc | 2023-12-31 | 6.2 M |
NUS Fundamentals
Return On Equity | 0.01 | ||||
Return On Asset | 0.0461 | ||||
Profit Margin | 0 % | ||||
Operating Margin | 0.19 % | ||||
Current Valuation | 961.64 M | ||||
Shares Outstanding | 49.66 M | ||||
Shares Owned By Insiders | 2.16 % | ||||
Shares Owned By Institutions | 85.17 % | ||||
Number Of Shares Shorted | 1.42 M | ||||
Price To Earning | 10.70 X | ||||
Price To Book | 0.72 X | ||||
Price To Sales | 0.30 X | ||||
Revenue | 1.97 B | ||||
Gross Profit | 1.59 B | ||||
EBITDA | 137.66 M | ||||
Net Income | 8.6 M | ||||
Cash And Equivalents | 264.73 M | ||||
Cash Per Share | 7.69 X | ||||
Total Debt | 607.33 M | ||||
Debt To Equity | 0.59 % | ||||
Current Ratio | 2.30 X | ||||
Book Value Per Share | 16.61 X | ||||
Cash Flow From Operations | 118.64 M | ||||
Short Ratio | 1.61 X | ||||
Earnings Per Share | 0.17 X | ||||
Price To Earnings To Growth | 2.35 X | ||||
Target Price | 15.5 | ||||
Number Of Employees | 3.7 K | ||||
Beta | 1.1 | ||||
Market Capitalization | 633.22 M | ||||
Total Asset | 1.81 B | ||||
Retained Earnings | 1.87 B | ||||
Working Capital | 373 M | ||||
Current Asset | 706.39 M | ||||
Current Liabilities | 407.6 M | ||||
Annual Yield | 0.02 % | ||||
Five Year Return | 3.09 % | ||||
Net Asset | 1.81 B | ||||
Last Dividend Paid | 1.56 |
About Nu Skin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nu Skin Enterprises's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nu Skin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nu Skin Enterprises based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Nu Skin Piotroski F Score and Nu Skin Altman Z Score analysis. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for NUS Stock analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know NUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.88) | Dividend Share 1.56 | Earnings Share 0.17 | Revenue Per Share 39.612 | Quarterly Revenue Growth (0.07) |
The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of NUS that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nu Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.